T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Microsoft
MSFT
|
$1.55B |
| 2 |
Netflix
NFLX
|
$1.26B |
| 3 |
Elevance Health
ELV
|
$1.08B |
| 4 |
Royal Caribbean
RCL
|
$873M |
| 5 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
$754M |
Top Sells
| 1 |
Baidu
BIDU
|
$1.46B |
| 2 |
PCP
PRECISION CASTPARTS CORP
PCP
|
$1.35B |
| 3 |
Biogen
BIIB
|
$1.3B |
| 4 |
McKesson
MCK
|
$1.05B |
| 5 |
HSP
HOSPIRA INC
HSP
|
$988M |
Sector Composition
| 1 | Healthcare | 21.75% |
| 2 | Consumer Discretionary | 14.84% |
| 3 | Financials | 13.91% |
| 4 | Technology | 11.11% |
| 5 | Industrials | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Lowe's Companies
LOW
$145B
| $3B | 0.67% | 43,595,758 -3,511,959 | -7% | -$242M |
|
27
Thermo Fisher Scientific
TMO
$186B
| $2.91B | 0.65% | 23,807,307 +2,456,850 | +12% | +$300M |
|
28
AutoZone
AZO
$70.2B
| $2.86B | 0.64% | 3,947,671 +17,056 | +0.4% | +$12.3M |
|
29
American Tower
AMT
$95.5B
| $2.85B | 0.63% | 32,393,124 -557,886 | -2% | -$49.1M |
|
30
Intuitive Surgical
ISRG
$170B
| $2.81B | 0.63% | 6,118,540 +62,466 | +1% | +$28.7M |
|
31
Salesforce
CRM
$245B
| $2.72B | 0.61% | 39,244,796 -1,731,135 | -4% | -$120M |
|
32
Bristol-Myers Squibb
BMY
$96B
| $2.48B | 0.55% | 41,928,627 +8,426,181 | +25% | +$499M |
|
33
Walt Disney
DIS
$213B
| $2.48B | 0.55% | 24,230,772 +1,403,828 | +6% | +$143M |
|
34
Bank of New York Mellon
BK
$74.5B
| $2.39B | 0.53% | 61,048,236 +9,896,404 | +19% | +$387M |
|
35
Intercontinental Exchange
ICE
$101B
| $2.32B | 0.52% | 9,870,944 +713,101 | +8% | +$168M |
|
36
Roper Technologies
ROP
$56.6B
| $2.32B | 0.52% | 14,788,326 -422,624 | -3% | -$66.2M |
|
37
Exxon Mobil
XOM
$487B
| $2.27B | 0.5% | 30,496,203 +4,094,730 | +16% | +$304M |
|
38
Becton Dickinson
BDX
$55.3B
| $2.23B | 0.5% | 16,836,276 +2,636,166 | +19% | +$350M |
|
39
Regeneron Pharmaceuticals
REGN
$61.5B
| $2.23B | 0.5% | 4,798,155 +551,370 | +13% | +$256M |
|
40
FirstEnergy
FE
$25.2B
| $2.21B | 0.49% | 70,587,504 +9,316,748 | +15% | +$292M |
|
41
Starbucks
SBUX
$100B
| $2.18B | 0.49% | 38,423,073 -8,009,535 | -17% | -$455M |
|
42
PG&E
PCG
$33.6B
| $2.14B | 0.48% | 40,451,940 +7,024,016 | +21% | +$371M |
|
43
CVS Health
CVS
$92.8B
| $2.12B | 0.47% | 21,979,439 +1,899,084 | +9% | +$183M |
|
44
Incyte
INCY
$16.5B
| $2.12B | 0.47% | 19,202,896 -1,546,633 | -7% | -$171M |
|
45
State Street
STT
$32.6B
| $2.06B | 0.46% | 30,656,281 +3,022,426 | +11% | +$203M |
|
46
Cigna
CI
$80.3B
| $2.06B | 0.46% | 15,255,194 -4,289,766 | -22% | -$579M |
|
47
Tesla
TSLA
$1.08T
| $1.99B | 0.44% | 8,011,439 +855,187 | +12% | +$212M |
|
|
LNKD
48
DELISTED
LinkedIn Corporation
LNKD
| $1.91B | 0.43% | 10,072,041 +1,327,858 | +15% | +$252M |
|
49
Johnson & Johnson
JNJ
$427B
| $1.9B | 0.42% | 20,381,476 +1,444,505 | +8% | +$135M |
|
50
Wells Fargo
WFC
$263B
| $1.86B | 0.41% | 36,266,653 -7,085,843 | -16% | -$364M |
|